- Release Date: 12/03/24 12:08
- Summary: Next Cohort Dosing Ph I/II UTI/Urosepsis Clinical Trial
- Price Sensitive: Yes
- Download Document 262.97KB
- Forums
- ASX - By Stock
- RCE
- Ann: Next Cohort Dosing Ph I/II UTI/Urosepsis Clinical Trial
RCE
recce pharmaceuticals ltd
Add to My Watchlist
9.33%
!
41.0¢

Ann: Next Cohort Dosing Ph I/II UTI/Urosepsis Clinical Trial
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
41.0¢ |
Change
0.035(9.33%) |
Mkt cap ! $118.5M |
Open | High | Low | Value | Volume |
38.0¢ | 41.5¢ | 38.0¢ | $49.36K | 121.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 180 | 40.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
41.5¢ | 33302 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2192 | 0.410 |
1 | 180 | 0.405 |
2 | 30711 | 0.400 |
1 | 5000 | 0.390 |
1 | 17780 | 0.385 |
Price($) | Vol. | No. |
---|---|---|
0.415 | 33302 | 3 |
0.430 | 30000 | 1 |
0.440 | 8669 | 2 |
0.445 | 1286 | 2 |
0.450 | 135223 | 6 |
Last trade - 14.33pm 11/08/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
WIN
WIN METALS LTD
Steve Norregard, CEO & MD
Steve Norregard
CEO & MD
SPONSORED BY The Market Online